RI 36 (Oxymorphone Hydrochloride Extended-Release 7.5 mg)
Pill with imprint RI 36 is Gray, Round and has been identified as Oxymorphone Hydrochloride Extended-Release 7.5 mg. It is supplied by Ranbaxy Pharmaceuticals Inc.
Oxymorphone is used in the treatment of pain; labor pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Oxymorphone 7.5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for RI 36
Oxymorphone Hydrochloride Extended-Release
- Imprint
- RI 36
- Strength
- 7.5 mg
- Color
- Gray
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Narcotic analgesics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Ranbaxy Pharmaceuticals Inc.
- National Drug Code (NDC)
- 63304-0219
- Inactive Ingredients
-
hypromelloses,
polyethylene glycol,
microcrystalline cellulose,
sodium stearyl fumarate,
magnesium silicate,
titanium dioxide,
silicon dioxide,
ferrosoferric oxide,
ferric oxide yellow,
polyvinyl alcohol
Note: Inactive ingredients may vary.
Related images for "RI 36"
More about oxymorphone
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (216)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: narcotic analgesics
Patient resources
- Drug Information
- Oxymorphone (Advanced Reading)
- Oxymorphone Injection (Advanced Reading)
- Oxymorphone Extended-Release Tablets
- Oxymorphone Tablets
- Oxymorphone Injection
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.